ArticleOncology letters2013

Increased intratumoral fluorothymidine uptake levels following multikinase inhibitor sorafenib treatment in a human renal cell carcinoma xenograft model.

Masahiro Murakami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.